Michael J. Mina

9.6k total citations · 2 hit papers
59 papers, 4.6k citations indexed

About

Michael J. Mina is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Michael J. Mina has authored 59 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 20 papers in Epidemiology and 14 papers in Modeling and Simulation. Recurrent topics in Michael J. Mina's work include SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (15 papers) and COVID-19 epidemiological studies (14 papers). Michael J. Mina is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (15 papers) and COVID-19 epidemiological studies (14 papers). Michael J. Mina collaborates with scholars based in United States, United Kingdom and Netherlands. Michael J. Mina's co-authors include Roy Parker, Daniel B. Larremore, Stephen J. Elledge, Yumei Leng, Bryan T. Grenfell, Brian C. Healy, Marianna Cortese, Kjetil Bjørnevik, Kassandra L. Munger and David W. Niebuhr and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Michael J. Mina

58 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

2022 1.1k citations Michael J. Mina, Yumei Leng et al. Science profile →
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

2021 565 citations James A. Hay, Michael J. Mina et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Mina United States	30	2.2k	1.1k	792	772	700	59	4.6k
Michal Mandelboim Israel	34	2.3k 1.0×	1.3k 1.2×	348 0.4×	1.1k 1.5×	1.0k 1.5×	158	5.0k
Wenbo Xu China	40	3.3k 1.5×	2.3k 2.1×	255 0.3×	576 0.7×	1.0k 1.4×	259	6.0k
Corine H. GeurtsvanKessel Netherlands	30	2.3k 1.0×	727 0.7×	198 0.3×	1.3k 1.7×	530 0.8×	101	4.1k
Nathalie Bastien Canada	43	2.6k 1.2×	3.4k 3.1×	524 0.7×	429 0.6×	773 1.1×	104	5.5k
Alba Grifoni United States	30	5.5k 2.5×	585 0.5×	480 0.6×	1.9k 2.4×	1.8k 2.5×	116	7.0k
Qiuwei Pan Netherlands	46	2.0k 0.9×	1.9k 1.8×	208 0.3×	1.2k 1.6×	2.2k 3.2×	235	7.9k
Yang Pan China	27	2.6k 1.2×	624 0.6×	449 0.6×	719 0.9×	913 1.3×	135	5.1k
Miles P. Davenport Australia	54	4.3k 1.9×	1.8k 1.7×	441 0.6×	4.7k 6.1×	2.0k 2.9×	256	10.8k
Debby van Riel Netherlands	36	3.4k 1.6×	3.9k 3.6×	446 0.6×	1.2k 1.6×	689 1.0×	84	6.9k
Vineet D. Menachery United States	41	6.2k 2.8×	748 0.7×	512 0.6×	1.3k 1.7×	1.6k 2.2×	86	7.9k

Countries citing papers authored by Michael J. Mina

Since Specialization

Citations

This map shows the geographic impact of Michael J. Mina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Mina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Mina more than expected).

Fields of papers citing papers by Michael J. Mina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Mina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Mina. The network helps show where Michael J. Mina may publish in the future.

Co-authorship network of co-authors of Michael J. Mina

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Mina. A scholar is included among the top collaborators of Michael J. Mina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Mina. Michael J. Mina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Li‐Ting, Manjusha Thakar, Shristi Ghimire, et al.. (2025). Remdesivir postexposure prophylaxis limits measles-induced “immune amnesia” and measles antibody responses in macaques. JCI Insight. 10(11).

Kahn, Rebecca, Inga Holmdahl, Sujan Reddy, et al.. (2021). Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes. Clinical Infectious Diseases. 74(4). 597–603. 30 indexed citations

Goudsmit, Jaap, Anita H.J. van den Biggelaar, Wouter Koudstaal, et al.. (2021). Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program. European Journal of Epidemiology. 36(7). 753–762. 14 indexed citations

Saad-Roy, Chadi M., Sinead E. Morris, C. Jessica E. Metcalf, et al.. (2021). Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. 372(6540). 363–370. 126 indexed citations

Wagner, Caroline E., Chadi M. Saad-Roy, Sinead E. Morris, et al.. (2021). Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science. 373(6562). eabj7364–eabj7364. 66 indexed citations

Biering, Scott B., David L. Akey, Marcus P. Wong, et al.. (2021). Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction. Science. 371(6525). 194–200. 99 indexed citations

Chin, Taylor, James A. Hay, Pablo M. De Salazar, et al.. (2021). Estimating internationally imported cases during the early COVID-19 pandemic. Nature Communications. 12(1). 311–311. 27 indexed citations

Dente, Christopher J., Michael J. Mina, Bryan C. Morse, et al.. (2021). Predicting the need for massive transfusion: Prospective validation of a smartphone-based clinical decision support tool. Surgery. 170(5). 1574–1580. 10 indexed citations

Petersen, Irene, et al.. (2021). Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus. Clinical Epidemiology. Volume 13. 935–940. 20 indexed citations

10.

Mina, Michael J. & Kristian G. Andersen. (2020). COVID-19 testing: One size does not fit all. Science. 371(6525). 126–127. 129 indexed citations

11.

Saad-Roy, Chadi M., Caroline E. Wagner, Rachel E. Baker, et al.. (2020). Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science. 370(6518). 811–818. 150 indexed citations

12.

Mina, Michael J., C. Jessica E. Metcalf, Adrian B. McDermott, et al.. (2020). A Global Immunological Observatory to meet a time of pandemics. eLife. 9. 51 indexed citations

13.

Bryant, Juliet E., Andrew S. Azman, Matthew J. Ferrari, et al.. (2020). Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Science Immunology. 5(47). 88 indexed citations

14.

Yang, Luojun, Bryan T. Grenfell, & Michael J. Mina. (2020). Waning immunity and re-emergence of measles and mumps in the vaccine era. Current Opinion in Virology. 40. 48–54. 32 indexed citations

15.

Mina, Michael J., Tomasz Kula, Yumei Leng, et al.. (2019). Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 366(6465). 599–606. 251 indexed citations

16.

Yang, Luojun, Bryan T. Grenfell, & Michael J. Mina. (2019). Measles vaccine immune escape: Should we be concerned?. European Journal of Epidemiology. 34(10). 893–896. 12 indexed citations

17.

Dodd, Caitlin, Gwen Masclee, Maria de Ridder, et al.. (2018). Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open. 8(11). e021465–e021465. 40 indexed citations

18.

Mina, Michael J., Rondi B. Gelbard, Jacquelyn S. Carr, et al.. (2016). Factors affecting mortality after penetrating cardiac injuries: 10-year experience at urban level I trauma center. The American Journal of Surgery. 213(6). 1109–1115. 27 indexed citations

19.

Mina, Michael J., C. Jessica E. Metcalf, Rik L. de Swart, Albert D. M. E. Osterhaus, & Bryan T. Grenfell. (2015). Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 348(6235). 694–699. 262 indexed citations

20.

Mina, Michael J., Keith P. Klugman, Jason W. Rosch, & Jonathan A. McCullers. (2014). Live Attenuated Influenza Virus Increases Pneumococcal Translocation and Persistence Within the Middle Ear. The Journal of Infectious Diseases. 212(2). 195–201. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact